This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Belluscura has developed the X-PLOR, a lightweight, portable oxygen delivery device aimed at treating the millions of people globally suffering from chronic lung diseases. The company plans to launch this novel and cost-effective device in the US in 2019, with Europe to follow.

  • Amount raised

    £543.17k

  • Company number

    09910883

  • Incorporation date

    10/12/2015

Details

  • Company number

    09910883

  • Incorporation date

    10/12/2015

  • Company status

    Active

  • Industry type

    Manufacture of consumer electronics

  • Number of current appointments

    3

15 Fetter Lane
London
EC4A 1BW

Crowdcube Funding History

Date Amount No. of Investors
23/04/2019 £543.17k 333 View

Key Financials

View all financials
2016 2017
Turnover £32.73k £274.76k
Cash £973.17k £140.81k
Increase in Cash £1.8m £-833.63k

Financial data drawn from last filed accounts don't necessarily reflect current trading activity.

Date Description Type
15/05/2019

Statement of capital following an allotment of shares on 2019-05-03

PDF
21/12/2018

Confirmation statement made on 2018-12-09 with updates

PDF
19/12/2018

Registered office address changed from 82 st. John Street Farringdon London EC1M 4JN England to 15 Fetter Lane London EC4A 1BW on 2018-12-19

PDF

People

Name Role Appointed Nationality
DYER, Anthony Stephen Secretary 17/11/2017 British
DYER, Anthony Stephen Director 17/11/2017 British
RAUKER, Robert Director 16/08/2016 American